Canntab Therapeutics Ltd (PILL.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
| 12-2017 | 05-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | N/A | 2 | N/A | N/A | N/A |
| Accounts receivable | 0 | 20 | -8 | -43 | 28 |
| Other Working Capital | 73 | 78 | -128 | -84 | 146 |
| Other Operating Activity | -188 | -454 | -273 | -131 | -204 |
| Operating Cash Flow | $-115 | $-355 | $-409 | $-258 | $-30 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -100 | N/A | N/A | N/A |
| Net Acquisitions | 0 | N/A | 1,166 | N/A | N/A |
| Investing Cash Flow | $0 | $-100 | $1,166 | $N/A | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 100 | 1,413 | N/A | 150 | N/A |
| Other Financing Activity | 0 | 0 | -852 | 201 | 0 |
| Financing Cash Flow | $100 | $1,413 | $-852 | $351 | $0 |
| Beginning Cash Position | 16 | 0 | 111 | 17 | 48 |
| End Cash Position | 1 | 959 | 16 | 111 | 17 |
| Net Cash Flow | $-15 | $959 | $-95 | $93 | $-30 |
| Free Cash Flow | |||||
| Operating Cash Flow | -115 | -355 | -409 | -258 | -30 |
| Capital Expenditure | N/A | -100 | N/A | N/A | N/A |
| Free Cash Flow | -115 | -454 | -409 | -258 | -30 |